Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
Mol Pharmacol. 2010 Jul;78(1):69-80. doi: 10.1124/mol.110.063727. Epub 2010 Apr 15.
We reported previously that ethanol treatment regulates D(1) receptor phosphorylation and signaling in a protein kinase C (PKC) delta- and PKCgamma-dependent fashion by a mechanism that may involve PKC isozyme-specific interacting proteins. Using a PKC isozyme-specific coimmunoprecipitation approach coupled to mass spectrometry, we report the identification of RanBP9 and RanBP10 as novel interacting proteins for both PKCgamma and PKCdelta. Both RanBP9 and RanBP10 were found to specifically coimmunoprecipitate with both PKCgamma and PKCdelta; however, this association did not seem to mediate the ethanol regulation of the PKCs. It is noteworthy that the D(1) receptor was also found to specifically coimmunoprecipitate with RanBP9/10 from human embryonic kidney (HEK) 293T cells and with endogenous RanBP9 from rat kidney. RanBP9 and RanBP10 were also found to colocalize at the cellular level with the D(1) receptor in both kidney and brain tissue. Although overexpression of RanBP9 or RanBP10 in HEK293T cells did not seem to alter the kinase activities of either PKCdelta or PKCgamma, both RanBP proteins regulated D(1) receptor phosphorylation, signaling, and, in the case of RanBP9, expression. Specifically, overexpression of either RanBP9 or RanBP10 enhanced basal D(1) receptor phosphorylation, which was associated with attenuation of D(1) receptor-stimulated cAMP accumulation. Moreover, treatment of cells with select PKC inhibitors blocked the RanBP9/10-dependent increase in basal receptor phosphorylation, suggesting that phosphorylation of the receptor by PKC is regulated by RanBP9/10. These data support the idea that RanBP9 and RanBP10 may function as signaling integrators and dictate the efficient regulation of D(1) receptor signaling by PKCdelta and PKCgamma.
我们之前报道过,乙醇处理通过一种可能涉及蛋白激酶 C(PKC)同工型特异性相互作用蛋白的机制,以 PKCδ和 PKCγ依赖性的方式调节 D1 受体磷酸化和信号转导。我们使用 PKC 同工型特异性共免疫沉淀方法结合质谱法,报告了 RanBP9 和 RanBP10 作为 PKCγ和 PKCδ的新型相互作用蛋白的鉴定。发现 RanBP9 和 RanBP10 都可以与 PKCγ和 PKCδ特异性共免疫沉淀;然而,这种关联似乎并不介导乙醇对 PKCs 的调节。值得注意的是,D1 受体也被发现可以从人胚肾(HEK)293T 细胞中与 RanBP9/10 特异性共免疫沉淀,并从大鼠肾脏中与内源性 RanBP9 特异性共免疫沉淀。RanBP9 和 RanBP10 也在肾和脑组织中与 D1 受体在细胞水平上共定位。尽管在 HEK293T 细胞中过表达 RanBP9 或 RanBP10 似乎不会改变 PKCδ或 PKCγ的激酶活性,但两种 RanBP 蛋白都调节 D1 受体的磷酸化、信号转导,并且在 RanBP9 的情况下,还调节其表达。具体而言,过表达 RanBP9 或 RanBP10 增强了基础 D1 受体磷酸化,这与 D1 受体刺激的 cAMP 积累的减弱有关。此外,用选择性 PKC 抑制剂处理细胞可阻断 RanBP9/10 依赖性基础受体磷酸化的增加,表明 PKC 对受体的磷酸化受 RanBP9/10 调节。这些数据支持这样一种观点,即 RanBP9 和 RanBP10 可能作为信号整合因子发挥作用,并决定 PKCδ和 PKCγ对 D1 受体信号的有效调节。